Tue.Oct 15, 2024

article thumbnail

GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV

Fierce Pharma

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA. In the complaints, GSK says it hopes to recover a “reasonable royalty” tied to Moderna’s vaccine sales, plus damages.

Sales 359
article thumbnail

Finding the Cure for Data Interoperability in Value-Based Care

MedCity News

Payers and providers alike are struggling with data interoperability. It’s clear that a more unified approach to data management is essential for payers to effectively navigate the complexities of value-based care. The post Finding the Cure for Data Interoperability in Value-Based Care appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche's Tecentriq

Fierce Pharma

Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer (ES- | Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer.

article thumbnail

On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test

MedCity News

In addition to meeting the main safety and tolerability goal, MieraGTx Holdings’ gene therapy for Parkinson’s disease also showed signs of efficacy. The one-time treatment is intended to reprogram dysfunctional brain circuits. The post On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test appeared first on MedCity News.

Safety 122
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Johnson & Johnson eases initial Stelara blows with strong Darzalex, Carvykti growth

Fierce Pharma

Johnson & Johnson's immunology superstar Stelara and oncology blockbuster Darzalex have long been among the company's top revenue contributors. | The company picked up a record $3 billion in quarterly sales for its multiple myeloma powerhouse Darzalex as it grooms Tremfya to take on Stelara's market dominance.

Sales 278
article thumbnail

GSK turns its guns on Moderna in mRNA jab patent dispute

pharmaphorum

GSK has filed lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and RSV

121
121

More Trending

article thumbnail

AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential

PharmaVoice

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

115
115
article thumbnail

The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights

MedCity News

PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies. The post The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights appeared first on MedCity News.

article thumbnail

Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid

pharmaphorum

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.The Danish drugmaker has offered $60 per share for California biotech Longboard, with the main asset in the deal bexicaserin, an oral, centrally acting serotonin 5-HT 2C receptor super-agonist in late-stage testing for seizures associated with rare forms of epilepsy.

article thumbnail

Headspace Introduces AI Companion To Support Patients Through ‘Ebbs and Flows’ of Life

MedCity News

Headspace recently introduced Ebb, an empathetic AI companion. It helps users reflect and sort through their emotions, and provides recommendations for mental health content. The post Headspace Introduces AI Companion To Support Patients Through ‘Ebbs and Flows’ of Life appeared first on MedCity News.

Patients 115
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Transgene cervical cancer shot misses the mark in phase 2

pharmaphorum

Transgene's therapeutic vaccine for cervical and anogenital cancers failed a phase 2 trial, but an efficacy signal warrants further study

111
111
article thumbnail

Parakeet Health Flies Onto The Scene to Automate Healthcare Call Centers

MedCity News

Generative AI-powered voice platform Parakeet Health announced its launch and $3 million in seed funding. The startup seeks to automate many of the interactions that patients have with their doctor’s staff, such as scheduling appointments and answering billing questions. The post Parakeet Health Flies Onto The Scene to Automate Healthcare Call Centers appeared first on MedCity News.

article thumbnail

US digital health spending set to increase, survey finds

pharmaphorum

Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey

article thumbnail

Celltrion unveils promising dose escalation results for subcutaneous infliximab

PharmaTimes

Study reveals potential new strategy for managing inflammatory bowel disease

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

LEO launches chronic hand eczema drug in its first market

pharmaphorum

Germany is the first market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema

Marketing 105
article thumbnail

Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn

Pharmaceutical Technology

Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare conditions.

article thumbnail

Alleo and Ubiquigent unite to accelerate drug discovery

PharmaTimes

Partnership to harness AI for DUB-focused preclinical programmes

92
article thumbnail

GITEX GLOBAL 2024: Huawei launches a series of industrial digital and intelligent transformation solutions, and flagship products

Pharmaceutical Technology

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ten industries.

97
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

PharmaVoice

Data readouts over the next six months could set expectations for how the highly lucrative market for weight loss therapies will look in the future.

article thumbnail

Chiesi Launches Biotech Center of Excellence in Parma, Italy

PharmaTech

The design of the center prioritizes integration of the entire supply chain, with the end goals of accelerating product development and autonomous production capacity in alignment with EU priorities.

59
article thumbnail

FDA Approves Imuldosa, Stelara Biosimilar For Treatment of Chronic Inflammatory Conditions

Pharmacy Times

Imuldosa has received approval for all indications of its reference product, including ulcerative colitis, psoriatic arthritis, and Crohn disease.

FDA 55
article thumbnail

Maximize Operational Flexibility and Efficiency without Compromising Quality

PharmaTech

Amid surging drug shortages and costly launch delays, it’s crucial to enhance operational flexibility and efficiency without compromising quality. Discover how end-to- end integrated automation systems can streamline your processes, improve flexibility, reduce time-to-market, maximize revenue, and drive continuous improvement. Transform your pharmaceutical manufacturing processes today!

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Is PBM Reform Nearing the Finish Line?

Pharmacy Times

Legislative efforts in the states and Washington, DC, have made progress, but there is still a way to go.

52
article thumbnail

Make Paperless Manufacturing a Reality for your Pharmaceutical Facility

PharmaTech

Revolutionize pharmaceutical manufacturing through paperless manufacturing. By eliminating paper-based processes, you can quickly centralize your data, reduce cost and time, minimize errors, and release products faster. Even the simplest “paper on glass” digital systems enable streamlined workflows and can ensure real-time data access and seamless communication.

article thumbnail

Transgene’s stock drops after Phase II cancer jab trial misses primary endpoint

Pharmaceutical Technology

Despite this setback, Transgene plans to explore the potential benefits of the vaccine in specific patient populations.

article thumbnail

BioDuro-Sundia Bolsters Drug Discovery Services with New Center in Shanghai

PharmaTech

The global CRDMO said its clients would be able to expedite R&D processes, thereby reducing costs and potentially leading to accelerated discovery of new candidate therapies.

Leads 52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Bayer applies for EU approval of menopause drug elinzanetant

Pharmaceutical Technology

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief pill.

article thumbnail

Assembly Required: Building Blocks in Biopharma

PharmExec

Highlighting two pieces beyond Pharm Exec's October headliners that draw interesting parallels when it comes to life sciences leadership and building teams and capability internally—whether new businesses or new brands.

article thumbnail

Lilly touts Omvoh’s superiority over J&J’s Stelara in Crohn’s

Pharmaceutical Technology

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its competitor.

52
article thumbnail

Pharmaceutical Executive: October 2024 Issue (PDF)

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A